How important is cervical cancer screening in women during pregnancy?

Share This Post

1. The importance of cervical cancer screening in women during pregnancy

Juvenile laryngeal papilloma is more common in children and adolescents, mainly pregnant women with low-risk HPV infection in the reproductive tract during pregnancy, which is caused by mother-to-child transmission to infants during delivery through the birth canal, mainly HPV infections type 6 and 11. Children with juvenile laryngeal papilloma may have no clinical symptoms in the early stage. As the laryngeal papilloma increases, respiratory symptoms appear. If the lesion is extensive, it may cause severe breathing difficulties and death. Screening of cervical cancer in pregnant women to prevent HPV infection can effectively prevent the virus from being transmitted to babies through childbirth. The birth of a healthy baby will undoubtedly contribute to individuals, families and society.

2. Methods of screening for cervical cancer in women during pregnancy. Routine high-risk HPV typing and liquid-based cytology tests are performed on women before pregnancy.

If the test result is positive, colposcopy is recommended. Colposcopy found a suspicious lesion and gave a cervical biopsy. If cervical cancer or precancerous lesions are found, wait for the cervical lesions to heal before considering fertility.

3. HPV infection in pregnant women. Pregnant women detect low-risk HPV infections in the reproductive tract before and after pregnancy, especially HPV types 6 and 11. The pregnant woman should be delivered by caesarean section to minimize the incidence of juvenile laryngeal papilloma.

Cervical cancer screening for pregnant women or women of appropriate age is particularly important, because this group of people bears the happiness of two or even three generations. Since the birth of a healthy baby, since human intervention can be used for disease prevention, medicine has developed so progressively. Medical technology can benefit people and prevent diseases before they happen. So, dear female compatriots, what are you waiting for? Hurry up and join the cervical cancer screening team.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma
CAR T-Cell therapy

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma

Chimeric antigen receptor (CAR) T-cells that specifically target Fibroblast Growth Factor Receptor 4 (FGFR4), a surface tyrosine receptor that is extensively expressed in rhabdomyosarcoma (RMS), are now undergoing clinical research. However, the effectiveness of these CAR T-cells may be hindered by tumor heterogeneity and inadequate activation. In this study, we present a method to enhance the co-stimulatory and targeting characteristics of a FGFR4 CAR through an optimization process. We substituted the hinge and transmembrane domain of CD8 as well as the 4-1BB co-stimulatory domain with the corresponding domains of CD28. The CARs produced exhibit heightened anti-tumor efficacy in multiple RMS xenograft models, with the exception of the RMS559 cell line, which is known for its aggressive nature.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy